Indications
- Estradiol Valerate and Estradiol Valerate/Dienogest is an estrogen/progestin COC indicated for use by women to prevent pregnancy. ( 1 )
- Treatment of heavy menstrual bleeding in women without organic pathology who choose to use an oral contraceptive as their method of contraception. ( 1.2 )
- The efficacy of Estradiol Valerate and Estradiol Valerate/Dienogest in women with a body mass index (BMI) of >30 kg/m 2 has not been evaluated. ( 1 , 8.8 )
1.1Oral Contraception Estradiol Valerate and Estradiol
Valerate/Dienogest is indicated for use by women to prevent pregnancy. The efficacy of Estradiol Valerate and Estradiol Valerate/Dienogest in women with a body mass index (BMI) of > 30 kg/m 2 has not been evaluated.
1.2Heavy Menstrual Bleeding Estradiol Valerate and Estradiol
Valerate/Dienogest is also indicated for the treatment of heavy menstrual bleeding in women without organic pathology who choose to use an oral contraceptive as their method of contraception [see Clinical Studies ( 14.2 )].
Contraindications
Do not prescribe Estradiol Valerate and Estradiol Valerate/Dienogest to women who are known to have the following:
- A high risk of arterial or venous thrombotic diseases. Examples include women who are known to:
- Smoke, if over age 35 [see Boxed Warning and Warnings and Precautions ( 5.1 )]
- Have deep vein thrombosis or pulmonary embolism, now or in the past [see Warnings and Precautions ( 5.1 )]
- Have cerebrovascular disease [see Warnings and Precautions ( 5.1 )]
- Have coronary artery disease [see Warnings and Precautions ( 5.1 )]
- Have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see Warnings and Precautions ( 5.1 )]
- Have inherited or acquired hypercoagulopathies [see Warnings and Precautions ( 5.1 )]
- Have uncontrolled hypertension [see Warnings and Precautions ( 5.4 )]
- Have diabetes mellitus with vascular disease [see Warnings and Precautions ( 5.6 )]
- Have headaches with focal neurological symptoms or have migraine headaches with or without aura if over age 35 [see Warnings and Precautions ( 5.7 )]
- Undiagnosed abnormal uterine bleeding [see Warnings and Precautions ( 5.8 )]
At a glance
- Brand name
- Natazia
- Active substance
- dienogest
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Bayer Hlthcare
- Status
- Prescription
- FDA approval
- 6 May 2010
- Application
- NDA022252-001



